69
Participants
Start Date
October 14, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
NovoTTF-200T
The NovoTTF-200T is a portable, battery operated system intended for continuous home use, which delivers TTFields at a frequency of 150kHz to the subject by means of insulated transducer arrays. TTFields exert electric forces intended to disrupt cancer cell division and induce immunogenic cell death.
Pembrolizumab
Pembrolizumab is an immune checkpoint inhibitor that helps the immune system recognize and attack cancer cells.
RECRUITING
Vitkovicka Nemocnice, Ostrava
RECRUITING
Hôpital Européen Marseille, Marseille
RECRUITING
Istituto Europeo di Oncologia, Milan
RECRUITING
Clínica Universidad de Navarra, Madrid, Madrid
RECRUITING
Centre Hospitalier Intercommunal de Cornouaille Service D'oncologie Médicale, Quimper
RECRUITING
Clínica Universidad de Navarra, Pamplona
RECRUITING
Montpellier University Hospital, Montpellier
RECRUITING
Hôpital Privé du Confluent Service D'oncologie Médicale, Nantes
RECRUITING
AOUS Policlinico Le Scotte U.O.C. Immunoterapia Oncologica, Siena
RECRUITING
Centre Léon Berard Service D'oncologie Médicale, Lyon
RECRUITING
APHP - Hôpital Ambroise-Paré, Boulogne-Billancourt
RECRUITING
Centre hospitalier intercommunal de Créteil Service de Pneumologie, Créteil
RECRUITING
Universitätsklinik f. Innere Medizin III, Salzburg
RECRUITING
Humanitas Gavazzeni Bergamo-U.O.Farmacia-Edificio D Piano -1, Bergamo
RECRUITING
Rijnstate Ziekenhuis, Arnhem
RECRUITING
Pratia MCM Kraków, Krakow
RECRUITING
MS Pneumed Janusz Milanowski, Katarzyna Szmygin-Milanowska Spó?ka Jawna, Lublin
RECRUITING
Hospital Universitario Arnau de Vilanova, Lleida
RECRUITING
Hospital Regional Universitario de Malaga (Hospital Civil), Málaga
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
RECRUITING
General University Hospital in Prague, Clinic of Oncology, Prague
RECRUITING
FN Motol, Prague
RECRUITING
AO SM Misericordia di Perugia, Perugia
RECRUITING
Hospital Universitario del Vinalopó, Elche
NovoCure GmbH
INDUSTRY